Janney Montgomery Scott’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$926K Sell
110,919
-25,050
-18% -$181K ﹤0.01% 1956
2026
Q2
$778K Buy
+135,969
New +$782K ﹤0.01% 2079
2025
Q2
– Sell
-124,751
Closed -$1.08M – 2798
2025
Q1
$1.08M Buy
124,751
+39,969
+47% +$244K ﹤0.01% 1491
2024
Q4
$412K Sell
84,782
-20,135
-19% -$113K ﹤0.01% 2113
2024
Q3
$810K Buy
+104,917
New +$933K ﹤0.01% 1643

Other funds holding OPRX

Janney Montgomery Scott's OPRX Position: Q3 2026 in Review

Janney Montgomery Scott reduced its OptimizeRx (OPRX) stake by 18% in Q3 2026, selling an estimated $181K and leaving 110,919 shares worth $926K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

Janney Montgomery Scott first reported a position in OPRX in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.08M in Q1 2025. 101 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.

  • Janney Montgomery Scott held 110,919 shares of OptimizeRx worth $926K as of Q3 2026.
  • Janney Montgomery Scott sold 25,050 OptimizeRx shares in Q3 2026, an estimated $181K.
  • OptimizeRx made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q3 2026, its #1956 holding.
  • Janney Montgomery Scott first reported a position in OptimizeRx in Q3 2024 and has held it in 5 quarters since.
  • Janney Montgomery Scott's OptimizeRx position peaked at $1.08M in Q1 2025.
  • 101 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.

Based on Janney Montgomery Scott's 13F filing for Q3 2026, filed 12 Nov 2026.